Retatrutide: The Triple Agonist That’s Rewriting the Rules of Weight Loss, Diabetes, and Fatty Liver Disease
Let’s be direct about something before we start: the weight-loss drug space has had no shortage of hype over the last few years. Ozempic made headlines. Mounjaro changed the conversation. And then, quietly, data started coming out about a molecule called retatrutide — and the researchers reading it went unusually silent for a moment. That…